Abstract
Glucose-regulated protein 78 (GRP78), a molecular chaperone, is overexpressed in patients suffering from obesity, fatty liver, hyperlipidemia and diabetes. GRP78, therefore, can be not only a biomarker to predict the progression and prognosis of obesity and metabolic diseases but also a potential therapeutic target for anti-obesity treatment. In this paper, GRP78 inhibitors targeting its ATPase domain have been reviewed. Small molecules and proteins that directly bind GRP78 have been described. Putative mechanisms of GRP78 in regulating lipid metabolism were also summarized so as to investigate the role of GRP78 in obesity and other related diseases and provide a theoretical basis for the development and design of anti-obesity drugs targeting GRP78.
Funder
University-level Project of Guangxi University of Traditional Chinese Medicine
Research Basic Ability Improvement Project of Young and Middle-aged Teachers in Guangxi Universities
USDA
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference80 articles.
1. WHO (2020). About Diabetes, World Health Organization.
2. (2022, September 30). Available online: https://www.worldobesity.org/news/world-obesity-day-all-countries-significantly-off-track-to-meet-2025-who-targets-on-obesity.
3. (2022, March 30). Available online: http://test.health-china.com/c/2021-09-22/803749.shtml.
4. (2022, September 30). Available online: https://www.fortunebusinessinsights.com/anti-obesity-drugs-market-104783.
5. Association between obesity and breast cancer: Molecular bases and the effect of flavonoids in signaling pathways;Crit. Rev. Food Sci. Nutr.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献